期刊文献+

肿瘤转移抑制基因KAI1对子宫内膜癌细胞增殖、侵袭能力的影响 被引量:2

Influence of metastasis suppressor gene KAI1 on proliferation and invasion of endometrial carcinoma cells
下载PDF
导出
摘要 目的:探讨肿瘤转移抑制基因KAI1基因对子宫内膜癌细胞(AN3CA和HEC-1-B)增殖及侵袭能力的影响。方法:脂质体介导pcDNA3-KAI1质粒转染人子宫内膜癌细胞AN3CA和HEC-1-B,采用免疫印迹法和流式细胞术检测转染前后肿瘤细胞KAI1蛋白的表达,MTT比色法、软琼脂克隆形成实验观察KAI1基因对肿瘤细胞增殖能力的影响,Transwell侵袭实验检测转染前后肿瘤细胞侵袭能力的变化。结果:转染pcDNA3-KAI1质粒后AN3CA和HEC-1-B细胞内和细胞表面均可检测到KAI1蛋白的稳定表达。转染空白质粒组细胞形成克隆数量多体积较大,细胞克隆形成率为(54.2±3.1)%和(52.7±4.3)%,细胞的倍增时间为21.3h和20.1h;基因转染pcDNA3-KAI1质粒组细胞形成克隆数少体积较小,细胞克隆形成率为(37.4±5.1)%和(32.1±3.7)%,细胞的倍增时间为43.7h和45.2h;两组间细胞增殖能力和克隆形成能力比较,差异均有统计学意义(P<0.05)。基因转染组细胞的穿膜细胞数为(91±10.7)/HT、(68±10.8)/HT,而空质粒转染组细胞的穿膜细胞数为(292±11.5)/HT、(219+12.7)/HT,两组细胞比较,侵袭能力亦显著下降(P<0.05)。结论:外源性肿瘤转移抑制基因KAI1有效转染可使子宫内膜癌细胞增殖、侵袭能力均下降,KAI1可能成为子宫内膜癌转移的新治疗靶点。 Objective: To investigate the influence of metastasis suppressor gene KAI1 on the proliferation, invasion and metastasis of endometrial carcinoma cell line AN3CA and HEC-1- B. Methods: The KAI1 cDNA was transfected into human endometrial carcinoma cells AN3CA and HEC-1-B via Lipofectamine 2000. The expression of KAI1 protein was examined by Western blotting and flow cytometry before and after transfection. The proliferation ability of AN3CA and HEC- 1-B cells was observed by MTT assay and anchorage-independent growth assay. The changes of cell invasive ability were studied by transwell assays. Results: Stable expression of KAI1 protein was observed in AN3CA and HEC-1- B cells and on their surface after transfection with pcDNA3-KAI1 plasmid. Cells transfected with blank plasmid formed more colonies and had a larger size, with the colony forming rates being(54.2 ± 3.1 ) % for AN3CA cells and (52.7±4.3 ) % for HEC- 1- B cells; the doubling time of AN3CA and HEC-1-B cells were 21.3 h and 20.1 h, respectively. Cells transfected with pcDNA3-KAI1 formed less colonies and had a smaller size, with the colony forming rates being ( 37.4 ±5. 1 ) % for AN3CA cells and (32.1±3.7)% for HEC-1- B cells; the doubling time of AN3CA and HEC-1-B cells were 43.7 h and 45.2 h, respectively. The cell proliferation abilities and colony-forming ability were significantly different between the two groups (P 〈 0.05 ). The trans-membrane cell numbers in pcDNA3-KAI1 transfected AN3 CA and HEC-1-B cells were (91 ± 10.7)/HT and (68 ± 10.8 )/HT, respectively; and in blank plasmid transfected cells were (292 ±11.5 )/HT and(219 ± 12.7 )/HT, respectively; there was significant difference between the two groups (P 〈0.05) . Conclusion: Exogenous metastasis suppressor KAI1 gene can effectively decrease the proliferation and invasive ability of human endometrial carcinoma cells ; KAI1 might be a potential target for treatment of metastasis of endometrial carcinoma.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2007年第5期445-449,共5页 Chinese Journal of Cancer Biotherapy
基金 国家重点基础研究发展(973)规划项目(No.2002CB513107) 国家自然科学基金项目(No.30528012) 海南省教育厅高校科研基金项目(No.HjKj200747) Supported by the Major State Basic Research Development Program of China(No.2002CB513107) National Natural Science Foundation of China(No.30528012) the Research Fund of Higher Education of Hainan Ministry of Education(No.Hjkj200747)
关键词 肿瘤转移抑制基因KAI1 子宫内膜癌 肿瘤侵袭 增殖 metastasis suppressor gene KAI 1 endometrial cancer invasion proliferation
  • 相关文献

参考文献11

  • 1Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis suppressor: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site [ J ]. J Urol, 2003, 169 (3) :1122-1134.
  • 2White A, Lamb PW, Barrett JC, et al. Frequent downregulation of the KAI1 ( CD82 ) metastasis suppressor protein in human cancer cell lines [J]. Oncogene, 1998,16(24) : 3143-3149.
  • 3Farhadieh RD, Smee R, Ow K, et al. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival [ J ]. Cancer Lett, 2004, 213(1): 91-98.
  • 4Jee B, Jin K, Hahn JH, et al. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway [ J]. Exp Mol Med, 2003, 35 ( 1 ) :30-37.
  • 5萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 金冬雁 黎盂枫 译.分子克隆实验指南[M](第2版)[M].北京:科学出版社,1992..
  • 6Liu FS,Dong JT, Chen JT, et al. KA I1 metastasis suppressor protein is down - regulated during the progression of human endometrial cancer[J]. Clin Cancer Res, 2003, 9 (4) : 1393-1398.
  • 7胡春霞,周金华,蒋学锋,刘荣华,翁丹卉,卢运萍,王世宣,马丁.肿瘤转移抑制基因KAI1在子宫内膜癌原发灶和转移灶组织中的表达及其临床意义[J].现代妇产科进展,2007,16(7):492-495. 被引量:3
  • 8Yang X, Wei LL, Tang C, et al. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells[J]. Cancer Res, 2001, 61(13): 5284-5288.
  • 9Zhang XA, He B, Zhou B, et al. Requirement of the p130CAS- Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration [ J ]. J Biol Chem, 2003, 278 ( 29 ) : 27319-27328.
  • 10Bandyopadhyay S, Zhan R, Chaudhuri A, et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression[ J]. Nat Med,2006,12( 8 ) : 933-938.

二级参考文献7

  • 1汤洁,施达仁,杨文涛,陆洪芬,蔡树模.上皮性卵巢癌转移抑制基因KAI1的表达及预后意义[J].中华医学杂志,2005,85(2):115-117. 被引量:5
  • 2White A,Lamb PW,Barrett JC.Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines[J].Oncogene,1998,16:3143-3149
  • 3Kauffman EC,Robinson VL,Stadler WM,et al.Metastasis suppressor:the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site[J].J Urol,2003,169:1122-1134
  • 4Farhadieh RD,Smee R,Ow K,et al.Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival[J].Cancer Lett,2004,213:91-98
  • 5Jee B,Jin K,Hahn JH,et al.Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-Dependent pathway[J].Exp Mol Med,2003,35:30-37
  • 6Liu FS,Dong JT,Chen JT,et al.KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer[J].Clin Cancer Res,2003,9:1393-1398
  • 7Schindl M,Birner P,Bachtiary B,et al.The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical carcinoma[J].Anticancer Res,2000,20:4551-4555

共引文献12

同被引文献17

  • 1Wei-Jun Jiang, Xiao-Bo Man, Liang Tang, Hong-Yin Song, Shen-Jing Li, Guo-Jun Cai, Xiu-Hua Qiu and He-Ping Hu Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai 200050, China Department of Gastroenterology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China Department of Phannacology, Second Military Medical University, Shanghai 200433, China.Gradual upregulation of OCI-5 expression during occurrence and progression of rat hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):257-261. 被引量:2
  • 2Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepetocellular carcinoma[ J]. Mod Pathol, 2005, 18(12) :1591-1598.
  • 3Hippo Y , Watanabe K , Watanabe A , et al . Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatoeelluar carcinoma[J]. Cancer Res, 2004, 64 ( 7 ) : 2418-2423.
  • 4Sung YK, Hwang SY, Park MK, et al. Glypican-3 is overex- pressed in human hepatocellular carcinoma [ J ]. Cancer Sci, 2003, 94 (3) : 259-262.
  • 5Midorikawa Y, Ishikawa S, Iwanari H, et al. Glypican-3, over expressed in hepatocelluar carcinoma, modul-ates FGF2 and BM P-7 signaling[J]. Int J Cancer, 2003, 103(4) :455465.
  • 6Kwaek MH, Choi BY, Sung YK. Cellular changes resulting from rorced expression of glypican-3 in hepatocellular carcinoma cells [J]. MolCells, 2005, 21(2): 224-228.
  • 7Jiang WJ, Man XB, Tang L, et al. Gradual upregulation of 0CI-5 expression during occurrence and progression of rat hepatoeellular carcinoma[ J]. Hepatobiliary Panereat Dis Int, 2006, 5 (2) : 257- 261.
  • 8Farooq M, Hwang SY, Park MK, et al. Blocking endogenous glypican-3 expression releases Hep3B cells from GI arrest [J]. Mol Cells, 2003, 15(3) : 356-360.
  • 9Sung YK, Hwang SY, Farooq M, et al. Growth promotion of HepG2 hepatoma ceils by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling[ J]. Exp Mol Med, 2003, 35(4) : 257-262.
  • 10Kim H, Xu GL, Borczuk AC, et al. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor[ J]. Am J Respir Cell Mol Biol,2003, 29(6) : 694-701.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部